G9290 NSCLC Histology — HCPCS Reimbursement | OpenPayer

Summary & Overview

HCPCS G9290: NSCLC Biopsy/Cytology Report Not Classified by Histologic Type

HCPCS Level II code G9290 denotes pathology or cytology reports for non‑small cell lung cancer (NSCLC) in which the specimen is not classified into a specific histologic subtype or is documented as NSCLC‑NOS with an explanation. This code flags gaps in histologic specificity that can affect treatment selection, biomarker testing decisions, and downstream care coordination on a national level. Key payers in coverage discussions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will find a concise overview of the clinical and coding purpose of G9290, how it relates to pathology reporting requirements, and the typical service settings where the code is used. The publication summarizes payer coverage patterns and benchmarks where available, highlights potential implications for clinical workflows and quality measurement, and summarizes recent policy considerations relevant to pathology documentation for lung cancer. Data limitations and absent elements from the input are noted where applicable. The content is national in scope and intended for billing administrators, pathology leaders, and policy analysts.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG9290HCPCS Level IIpathologynon-small cell lung cancerNSCLC-NOScytologybiopsy reportingclinical documentationmedical coding

Billing Code Overview

HCPCS Level II code G9290 indicates that a pathology report for a biopsy or cytology specimen from a patient with non‑small cell lung cancer (NSCLC) does not document classification into a specific histologic type, or documents classification as NSCLC‑NOS (not otherwise specified) with an explanation. This reflects incomplete or non‑specific histologic categorization in the pathology documentation.

Service type: Pathology/cytology reporting of lung cancer biopsy or cytology specimens
Typical site of service: Hospital pathology laboratory, independent pathology laboratory, or outpatient pathology services

Clinical & Coding Specifications

Clinical Context

A patient in their mid-60s with a history of smoking presents with a persistent lung mass identified on chest CT. The pulmonologist schedules a diagnostic tissue sampling procedure — commonly bronchoscopic biopsy, CT-guided transthoracic needle biopsy, or endobronchial ultrasound (EBUS) fine-needle aspiration — to obtain cytology and histology specimens. Specimens are submitted to surgical pathology. Pathology issues a biopsy and cytology specimen report diagnosing non–small cell lung cancer (NSCLC) but documents the tumor as "NSCLC, not otherwise specified (NSCLC-NOS)" without further histologic subclassification (eg, adenocarcinoma, squamous cell carcinoma) or without an explanatory statement justifying inability to classify (such as inadequate material, extensive crush artifact, or lack of immunohistochemical studies). Typical workflow steps include pre-procedure consent and imaging, procedure with specimen collection, specimen handling and labeling, submission to pathology, microscopic and ancillary testing (special stains, immunohistochemistry), and issuance of the final pathology report. This billing code G9290 applies when the final pathology report documents NSCLC but lacks classification into a specific histologic type and does not include an explanatory statement supporting NSCLC-NOS classification.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services

HCPCS G8713: Single-Pool Kt/V ≥ 1.2 (Dialysis Adequacy)

HCPCS-G9893-DILATED-MACULAR-EXAM-NOT-PERFORMED

HCPCS G9893: Dilated Macular Exam Not Performed

HCPCS-G0541-CAREGIVER-TRAINING-DIRECT-CARE-TECHNIQUES-30MIN

HCPCS G0541: Caregiver Training in Direct Care Strategies

HCPCS-G6042-AMPHETAMINE-METHAMPHETAMINE-TESTING

HCPCS G6042: Amphetamine or Methamphetamine Testing

HCPCS-G0569-PSYCHIATRIC-COLLABORATIVE-CARE-MANAGEMENT-SUBSEQUENT-MONTH

HCPCS G0569: Subsequent Psychiatric Collaborative Care Management

HCPCS-G9879-MDPP-CORE-MAINTENANCE-TWO-SESSIONS-5-PERCENT-WEIGHT-LOSS

HCPCS G9879: MDPP Core Maintenance Two Sessions with 5% Weight Loss

HCPCS-G9384-HCV-SCREENING-MEDICAL-EXCLUSION-DOCUMENTATION

HCPCS G9384: Documentation of Medical Exclusion from HCV Screening

HCPCS-G0204-DIAGNOSTIC-BILATERAL-MAMMOGRAPHY-CAD

HCPCS G0204: Diagnostic Mammography, Bilateral with CAD

HCPCS-G8666-SHOULDER-RESIDUAL-SCORE-NOT-MEASURED

HCPCS G8666: Shoulder Residual Score Not Measured

HCPCS-G8665-SHOULDER-FUNCTIONAL-STATUS-NOT-MEASURED-PATIENT-NOT-APPROPRIATE

HCPCS G8665: Shoulder Functional Status Not Measured, Patient Not Appropriate

Showing 1–10 of 1996

Taxonomy Code	Specialty	Notes
`207RP1001X`	Pulmonary Disease	Pulmonologists commonly perform bronchoscopic biopsies and EBUS-guided sampling.
`2084P0800X`	Thoracic Surgery	Thoracic surgeons perform transthoracic and surgical lung biopsies.
`207K00000X`	Anatomic Pathology	Pathologists interpret cytology and histology and issue the NSCLC diagnosis and report.
`364S00000X`	Diagnostic Radiology	Interventional radiologists perform CT-guided percutaneous lung biopsies.
`363L00000X`	Clinical Laboratory	Laboratory medicine specialists and cytotechnologists handle specimen processing and preliminary cytology screening.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C34.90`	Malignant neoplasm of unspecified part of unspecified bronchus or lung	Primary diagnosis for a lung mass suspected or confirmed as lung cancer; common indication for biopsy.
`C34.10`	Malignant neoplasm of upper lobe, bronchus or lung, unspecified	Location-specific lung cancer diagnosis prompting targeted biopsy of the identified lesion.
`C34.92`	Malignant neoplasm of unspecified part of right bronchus or lung	Variant site-specific code used when laterality is known; indicates need for diagnostic tissue evaluation.
`R91.8`	Other nonspecific abnormal finding of lung field	Imaging abnormality prompting diagnostic tissue sampling when malignancy is a concern.
`R09.3`	Abnormal sputum	Clinical sign that may prompt further investigation including bronchoscopic sampling and cytology.
`Z12.2`	Encounter for screening for malignant neoplasms of respiratory organs	Screening-related encounters that can lead to diagnostic procedures if imaging is abnormal.
`Z85.118`	Personal history of other malignant neoplasm of bronchus and lung	History that increases surveillance and likelihood of diagnostic biopsy when new lesions are identified.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`31628`	Bronchoscopy, rigid or flexible, with transbronchial lung biopsy, single lobe	Bronchoscopic tissue sampling technique that may yield specimens for diagnosis of NSCLC; often performed before pathology report.
`32405`	Biopsy, lung or pleural, percutaneous needle; with imaging guidance	CT-guided transthoracic needle biopsy commonly used to obtain core or cytology samples for lung mass evaluation.
`32607`	Thoracotomy with lung biopsy (wedge)	Surgical open lung biopsy to obtain larger tissue for definitive histologic classification when less invasive sampling is non-diagnostic.
`78607`	Nuclear medicine lung imaging (ventilation or perfusion) — diagnostic (general)	Imaging sometimes used in preoperative assessment or staging, complementary to biopsy workflow.
`88305`	Level IV surgical pathology, gross and microscopic examination	Common pathology CPT code for tissue specimen histologic evaluation and diagnosis; used by pathology when classifying NSCLC.
`88172`	Cytopathology, fine needle aspiration; immediate cytologic evaluation (eg, rapid onsite evaluation)	Rapid onsite evaluation (ROSE) during biopsy provides immediate cytology assessment to determine specimen adequacy, which affects final report classification.

OpenPayer